» Articles » PMID: 22856588

Patient Perspectives on Personalized Glucose Advisory Systems for Type 1 Diabetes Management

Overview
Date 2012 Aug 4
PMID 22856588
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Diabetes technology is rapidly advancing toward fully automated glucose control systems, but little is known about patient perspectives on these systems. This study aimed to gather qualitative and quantitative data on patient attitudes and concerns about using a personalized glucose advisory system (PGASystem) for diabetes management.

Subjects And Methods: Fifty-six adults with type 1 diabetes on insulin pump therapy participated in focus group interviews following use of an insulin pump and continuous glucose monitoring for 4 weeks in a parent study to develop a PGASystem. Focus groups were transcribed and coded for thematic content.

Results: All participants endorsed the desire to use a PGASystem, and the majority wanted advice from the system on all aspects of insulin delivery. However, participants indicated that they might be reluctant to follow such advice because of the following concerns: how the advice was generated, relinquishing control to automated technology, and inadequate personalization of the system. Participants believed the system would need to consider numerous factors related to their food, activities, and other personal information to provide optimally individualized advice. The majority also reported difficulties with behavioral event recording on their insulin pumps, and approximately one-third endorsed difficulty with accurate carbohydrate counting.

Conclusions: Adults with type 1 diabetes appear to be enthusiastic about using a PGASystem system for their diabetes management but also have significant concerns affecting their overall willingness to follow such a system's advice. Addressing these concerns will be crucial in the future development of glucose advisory and control technology.

Citing Articles

Hypoglycaemia Prevention, Awareness of Symptoms, and Treatment (HypoPAST): protocol for a 24-week hybrid type 1 randomised controlled trial of a fully online psycho-educational programme for adults with type 1 diabetes.

Halliday J, Holmes-Truscott E, Thuraisingam S, Soholm U, Chatterton M, Russell-Green S Trials. 2024; 25(1):725.

PMID: 39468682 PMC: 11520494. DOI: 10.1186/s13063-024-08556-1.


Patient experiences of continuous glucose monitoring and sensor-augmented insulin pump therapy for diabetes: A systematic review of qualitative studies.

Natale P, Chen S, Chow C, Cheung N, Martinez-Martin D, Caillaud C J Diabetes. 2023; 15(12):1048-1069.

PMID: 37551735 PMC: 10755613. DOI: 10.1111/1753-0407.13454.


Automated digital counselling with social network support as a novel intervention for patients with heart failure: protocol for randomised controlled trial.

Peiris R, Ross H, Chan C, Poon S, Auguste B, Rac V BMJ Open. 2023; 12(9):e059635.

PMID: 36691152 PMC: 9445232. DOI: 10.1136/bmjopen-2021-059635.


Impact of New Technologies for Middle-Aged and Older Patients: In-Depth Interviews With Type 2 Diabetes Patients Using Continuous Glucose Monitoring.

Chiu C, Chou Y, Chen Y, Du Y JMIR Diabetes. 2019; 4(1):e10992.

PMID: 30789351 PMC: 6403528. DOI: 10.2196/10992.


Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative Study.

Lawton J, Blackburn M, Rankin D, Allen J, Campbell F, Leelarathna L Diabetes Technol Ther. 2019; 21(3):119-127.

PMID: 30720338 PMC: 6434584. DOI: 10.1089/dia.2018.0306.


References
1.
Hovorka R . The future of continuous glucose monitoring: closed loop. Curr Diabetes Rev. 2008; 4(3):269-79. DOI: 10.2174/157339908785294479. View

2.
Cobelli C, Renard E, Kovatchev B . Artificial pancreas: past, present, future. Diabetes. 2011; 60(11):2672-82. PMC: 3198099. DOI: 10.2337/db11-0654. View

3.
Dassau E, Atlas E, Phillip M . Closing the loop. Int J Clin Pract Suppl. 2011; (170):20-5. DOI: 10.1111/j.1742-1241.2010.02575.x. View

4.
Zisser H . Clinical hurdles and possible solutions in the implementation of closed-loop control in type 1 diabetes mellitus. J Diabetes Sci Technol. 2011; 5(5):1283-6. PMC: 3208892. DOI: 10.1177/193229681100500537. View

5.
Penfornis A, Personeni E, Borot S . Evolution of devices in diabetes management. Diabetes Technol Ther. 2011; 13 Suppl 1:S93-102. DOI: 10.1089/dia.2011.0058. View